Scleral thickness reductions in patients with keratoconus suggest that the disorder's pathogenesis is not limited to the cornea.

Recent preliminary studies showed promising results with FS–DALK in eyes with ectatic diseases. [76] The advancement of the FS laser to produce corneal cuts and the recent lamellar keratoplasty ...

Within the last decade, ICRS technology proven itself as a safe and effective treatment option in corneal ectatic disease that allows refractive rehabilitation. The reversibility of the procedure ...

There is a simple discount patient access scheme for vamorolone. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

The application also contains the Ectasia View toolset — an assessment tool designed to track corneal ectatic changes — and combined ... a novel gene therapy for inherited retinal dystrophy due to ...

The FDA has granted a Rare Pediatric Disease Designation (RPDD) to HORA-PDE6b (eyeDNA Therapeutics), a novel gene therapy, for the treatment of patients with inherited retinal dystrophy (IRD) caused ...